Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Specific Population

Women (remove)

Filter by Topic

Reproductive and maternal health (remove)
- Pregnancy (remove)
Treatment (remove)
- HIV drugs (remove)
  - Dolutegravir (Tivicay) (remove)
  - Atazanavir (Reyataz) (1)
  - Raltegravir (Isentress, Isentress HD) (1)
- Side effects (1)

Filter by Infection

HIV (remove)

Filter by Resource Category

Research summary (5)

Search results

Current filters: HIV, Treatment, Reproductive and maternal health, English, Women, HIV drugs, Pregnancy, Dolutegravir (Tivicay)

5 search results

Decreasing the risk of neural tube defects with dolutegravir: From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage
Agencies issue caution about use of dolutegravir by pregnant HIV-positive women: 2018, CATIE
Research summary - Webpage
U.S. study reviews use and impact of integrase inhibitors in pregnancy: 2016, CATIE
Research summary - Webpage
A successful pregnancy and birth outcome with dolutegravir-based ART: From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage
Dolutegravir—Interaction with atazanavir during pregnancy: From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage

Events

Conference on Retroviruses and Opportunistic Infections (CROI)

International Antiviral Society – USA
March 6 to 10, 2021
Online

Canadian Liver Meeting 2021

Canadian Association for the Study of the Liver, the Canadian Network on Hepatitis C (CanHepC) and the Canadian Association of Hepatology Nurses
May 2 to May 5, 2021
Online

CAHR 2021

Canadian Association for HIV Research
May 5 to 7, 2021
Online

IAS Conference on HIV Science

International AIDS Society
July 18 to 21, 2021
Online

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.